• Karin Fryk, Christian Rylander, and Kristina Svennerholm.
• Department of Anesthesiology and Intensive Care, Sahlgrenska University Hospital, Goteborg, Sweden karin.fryk@vgregion.se.
• BMJ Case Rep. 2020 Sep 2; 13 (9).

AbstractHigh-risk pulmonary embolism (PE) is a life-threatening condition that must be recognised and treated rapidly. The importance of correct risk stratification to guide therapeutic decisions has prompted the introduction of multidisciplinary PE response teams (PERTs). The recommended first-line treatment for high-risk PE is intravenous thrombolysis. Alternatives to consider if thrombolysis has insufficient effect or may cause significant haemorrhagic complications include catheter-directed intervention (CDI) and surgical thrombectomy. For patients in deep shock or cardiac arrest, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) can be instituted for cardiopulmonary rescue and support during CDI, thrombectomy or pharmacological treatment. We present a complex case of high-risk PE that illustrates the importance of an early PERT conference and repeated decision-making when the initial therapy fails. After a trial of thrombolysis with insufficient effect, VA-ECMO was used to reverse circulatory and respiratory collapse in a patient with PE and recurrent episodes of cardiac arrest.© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

37 keywords...

hide…